Abiraterone
The metabolism of Esomeprazole can be decreased when combined with Abiraterone.
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Esomeprazole.
Alendronate
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Esomeprazole.
Advertisement
Alendronic acid
The therapeutic efficacy of Alendronic acid can be decreased when used in combination with Esomeprazole.
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Esomeprazole.
Ambrisentan
The metabolism of Ambrisentan can be decreased when combined with Esomeprazole.
Advertisement
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Esomeprazole.
Amiodarone
The metabolism of Esomeprazole can be decreased when combined with Amiodarone.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Esomeprazole.
Advertisement
Amoxicillin
The metabolism of Amoxicillin can be decreased when combined with Esomeprazole.
Amoxicillin Anhydrous
The metabolism of Amoxicillin can be decreased when combined with Esomeprazole.
Amphetamine
Esomeprazole can cause an increase in the absorption of Amphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Anhydrous Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Esomeprazole.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Esomeprazole.
Apalutamide
The serum concentration of Esomeprazole can be decreased when it is combined with Apalutamide.
Apixaban
The metabolism of Apixaban can be decreased when combined with Esomeprazole.
Aprepitant
The serum concentration of Esomeprazole can be increased when it is combined with Aprepitant.
Arformoterol
The metabolism of Arformoterol can be decreased when combined with Esomeprazole.
Armodafinil
The metabolism of Esomeprazole can be decreased when combined with Armodafinil.
Artemether
The metabolism of Artemether can be decreased when combined with Esomeprazole.
Atazanavir
Esomeprazole can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy.
Atomoxetine
The metabolism of Esomeprazole can be decreased when combined with Atomoxetine.
Axitinib
The metabolism of Axitinib can be decreased when combined with Esomeprazole.
Azelastine
The metabolism of Azelastine can be decreased when combined with Esomeprazole.
Benztropine
The metabolism of Benzatropine can be decreased when combined with Esomeprazole.
Boceprevir
The metabolism of Esomeprazole can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Esomeprazole can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Esomeprazole can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be decreased when it is combined with Esomeprazole.
Bosutinib monohydrate
The serum concentration of Bosutinib can be decreased when it is combined with Esomeprazole.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Esomeprazole.
Bromazepam
The metabolism of Bromazepam can be decreased when combined with Esomeprazole.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Esomeprazole.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Esomeprazole.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Esomeprazole.
Carbamazepine
The metabolism of Esomeprazole can be increased when combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Esomeprazole.
Carisoprodol
The metabolism of Carisoprodol can be decreased when combined with Esomeprazole.
Cefditoren
The serum concentration of Cefditoren can be decreased when it is combined with Esomeprazole.
Ceritinib
The serum concentration of Esomeprazole can be increased when it is combined with Ceritinib.
Chloramphenicol
The metabolism of Esomeprazole can be decreased when combined with Chloramphenicol.
Chlormethiazole
The metabolism of clomethiazole can be decreased when combined with Esomeprazole.
Chlorpropamide
The metabolism of Chlorpropamide can be decreased when combined with Esomeprazole.
Cholecalciferol
The metabolism of Esomeprazole can be decreased when combined with Cholecalciferol.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Esomeprazole.
Cimetidine
The metabolism of Esomeprazole can be decreased when combined with Cimetidine.
Cisapride
The metabolism of Cisapride can be decreased when combined with Esomeprazole.
Citalopram
The serum concentration of Citalopram can be increased when it is combined with Esomeprazole.
Clarithromycin
The metabolism of Esomeprazole can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Esomeprazole can be decreased when combined with Clemastine.
Clobazam
The metabolism of Clobazam can be decreased when combined with Esomeprazole.
Clodronic Acid
The therapeutic efficacy of Clodronic Acid can be decreased when used in combination with Esomeprazole.
Clofezone
The metabolism of Rabeprazole can be decreased when combined with Esomeprazole.
Clomipramine
The metabolism of Clomipramine can be decreased when combined with Esomeprazole.
Clopidogrel
Esomeprazole may decrease the antiplatelet activities of Clopidogrel.
Clotiazepam
The metabolism of Clotiazepam can be decreased when combined with Esomeprazole.
Clotrimazole
The metabolism of Esomeprazole can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Clozapine can be decreased when combined with Esomeprazole.
Cobicistat
The metabolism of Esomeprazole can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Esomeprazole.
Crizotinib
The metabolism of Esomeprazole can be decreased when combined with Crizotinib.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Esomeprazole.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Esomeprazole.
Cyclosporine
The metabolism of Esomeprazole can be decreased when combined with Cyclosporine.
Cysteamine
The therapeutic efficacy of Cysteamine can be decreased when used in combination with Esomeprazole.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be reduced when Dabigatran etexilate is used in combination with Esomeprazole resulting in a loss in efficacy.
Dabrafenib
The serum concentration of Dabrafenib can be decreased when it is combined with Esomeprazole.
Dapsone
The metabolism of Dapsone can be decreased when combined with Esomeprazole.
Darunavir
The metabolism of Esomeprazole can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Dasatinib can be decreased when it is combined with Esomeprazole.
Dasatinib Anhydrous
The serum concentration of Dasatinib can be decreased when it is combined with Esomeprazole.
Deferasirox
The serum concentration of Esomeprazole can be decreased when it is combined with Deferasirox.
Delavirdine
The serum concentration of Delavirdine can be decreased when it is combined with Esomeprazole.
Desipramine
The metabolism of Desipramine can be decreased when combined with Esomeprazole.
Dexlansoprazole
The metabolism of Dexlansoprazole can be decreased when combined with Esomeprazole.
Dexmethylphenidate
Esomeprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextroamphetamine
Esomeprazole can cause an increase in the absorption of Dextroamphetamine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Esomeprazole.
Diazepam
The metabolism of Diazepam can be decreased when combined with Esomeprazole.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Esomeprazole.
Dicumarol
The serum concentration of Dicoumarol can be increased when it is combined with Esomeprazole.
Dihydroergotamine
The metabolism of Esomeprazole can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Esomeprazole can be decreased when combined with Diltiazem.
Diphenhydramine
The metabolism of Diphenhydramine can be decreased when combined with Esomeprazole.
Dopamine
The metabolism of Dopamine can be decreased when combined with Esomeprazole.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Esomeprazole.
Doxepin
The metabolism of Doxepin can be decreased when combined with Esomeprazole.
Doxycycline
The metabolism of Esomeprazole can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Esomeprazole can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Esomeprazole can be decreased when combined with Dronedarone.
Efavirenz
The metabolism of Esomeprazole can be decreased when combined with Efavirenz.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Esomeprazole.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Esomeprazole.
Enfuvirtide
The metabolism of Enfuvirtide can be decreased when combined with Esomeprazole.
Enzalutamide
The serum concentration of Esomeprazole can be decreased when it is combined with Enzalutamide.
Erlotinib
The serum concentration of Erlotinib can be decreased when it is combined with Esomeprazole.
Erythromycin
The metabolism of Esomeprazole can be decreased when combined with Erythromycin.
Escitalopram
The metabolism of Escitalopram can be decreased when combined with Esomeprazole.
Eslicarbazepine Acetate
The metabolism of Esomeprazole can be decreased when combined with Eslicarbazepine acetate.
Estradiol
The metabolism of Estradiol can be decreased when combined with Esomeprazole.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Esomeprazole.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Esomeprazole.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Esomeprazole.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Esomeprazole.
Etidronate
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Esomeprazole.
Etidronic Acid
The therapeutic efficacy of Etidronic acid can be decreased when used in combination with Esomeprazole.
Etravirine
The metabolism of Etravirine can be decreased when combined with Esomeprazole.
Famotidine
The metabolism of Famotidine can be decreased when combined with Esomeprazole.
Ferric Carboxymaltose
Esomeprazole can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Esomeprazole can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluconazole
The serum concentration of Esomeprazole can be increased when it is combined with Fluconazole.
Fluindione
The serum concentration of Fluindione can be increased when it is combined with Esomeprazole.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Esomeprazole.
Fluoxetine
The metabolism of Fluoxetine can be decreased when combined with Esomeprazole.
Flutamide
The metabolism of Flutamide can be decreased when combined with Esomeprazole.
Fluvoxamine
The metabolism of Esomeprazole can be decreased when combined with Fluvoxamine.
Formoterol
The metabolism of Formoterol can be decreased when combined with Esomeprazole.
Fosamprenavir
The metabolism of Esomeprazole can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Esomeprazole can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Esomeprazole can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Esomeprazole can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Esomeprazole can be increased when it is combined with Fusidic Acid.
Gefitinib
The serum concentration of Gefitinib can be decreased when it is combined with Esomeprazole.
Gemfibrozil
The metabolism of Esomeprazole can be decreased when combined with Gemfibrozil.
Gliclazide
The metabolism of Gliclazide can be decreased when combined with Esomeprazole.
Glucosamine
The metabolism of Glucosamine can be decreased when combined with Esomeprazole.
Glyburide
The metabolism of Glyburide can be decreased when combined with Esomeprazole.
Guanfacine
The metabolism of Guanfacine can be decreased when combined with Esomeprazole.
Haloperidol
The metabolism of Haloperidol can be decreased when combined with Esomeprazole.
Hexobarbital
The metabolism of Hexobarbital can be decreased when combined with Esomeprazole.
Hypoxis hemerocallidea root extract
The serum concentration of Esomeprazole can be decreased when it is combined with St. John's Wort.
Ibandronate
The therapeutic efficacy of Ibandronate can be decreased when used in combination with Esomeprazole.
Ibandronic Acid
The therapeutic efficacy of Ibandronate can be decreased when used in combination with Esomeprazole.
Ibuprofen
The metabolism of Ibuprofen can be decreased when combined with Esomeprazole.
Idelalisib
The metabolism of Esomeprazole can be decreased when combined with Idelalisib.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Esomeprazole.
Imatinib
The metabolism of Esomeprazole can be decreased when combined with Imatinib.
Imipramine
The metabolism of Imipramine can be decreased when combined with Esomeprazole.
Indinavir
The serum concentration of Indinavir can be decreased when it is combined with Esomeprazole.
INDINAVIR ANHYDROUS
The serum concentration of Indinavir can be decreased when it is combined with Esomeprazole.
Indomethacin
The metabolism of Indomethacin can be decreased when combined with Esomeprazole.
Iron
Esomeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Esomeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
Esomeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron-Dextran Complex
Esomeprazole can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isavuconazole
The serum concentration of Esomeprazole can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Esomeprazole can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Esomeprazole can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Esomeprazole can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Itraconazole can be decreased when it is combined with Esomeprazole.
Ivacaftor
The serum concentration of Esomeprazole can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Esomeprazole.
Ketoconazole
The serum concentration of Ketoconazole can be decreased when it is combined with Esomeprazole.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Esomeprazole.
Lapatinib
The metabolism of Lapatinib can be decreased when combined with Esomeprazole.
Ledipasvir
The serum concentration of Ledipasvir can be decreased when it is combined with Esomeprazole.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Esomeprazole.
Lopinavir
The metabolism of Esomeprazole can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Esomeprazole.
Lovastatin
The metabolism of Esomeprazole can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Esomeprazole can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Esomeprazole can be decreased when it is combined with Lumacaftor.
Macitentan
The metabolism of Macitentan can be decreased when combined with Esomeprazole.
Medronate
The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Esomeprazole.
Melatonin
The metabolism of Melatonin can be decreased when combined with Esomeprazole.
Meperidine
The metabolism of Pethidine can be decreased when combined with Esomeprazole.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Esomeprazole.
Mephobarbital
The metabolism of Methylphenobarbital can be decreased when combined with Esomeprazole.
Meprobamate
The metabolism of Meprobamate can be decreased when combined with Esomeprazole.
Mesalamine
The therapeutic efficacy of Mesalazine can be decreased when used in combination with Esomeprazole.
Methadone
The metabolism of Methadone can be decreased when combined with Esomeprazole.
Methotrexate
The serum concentration of Methotrexate can be increased when it is combined with Esomeprazole.
Methsuximide
The metabolism of Methsuximide can be decreased when combined with Esomeprazole.
Methylphenidate
Esomeprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.
Metoprolol
The metabolism of Metoprolol can be decreased when combined with Esomeprazole.
Mifepristone
The serum concentration of Esomeprazole can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Esomeprazole can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Moclobemide can be decreased when combined with Esomeprazole.
Modafinil
The metabolism of Esomeprazole can be decreased when combined with Modafinil.
MYCOPHENOLATE
The serum concentration of Mycophenolic acid can be decreased when it is combined with Esomeprazole.
Mycophenolic Acid
The serum concentration of Mycophenolic acid can be decreased when it is combined with Esomeprazole.
Nefazodone
The metabolism of Esomeprazole can be decreased when combined with Nefazodone.
Nelfinavir
The serum concentration of the active metabolites of Nelfinavir can be reduced when Nelfinavir is used in combination with Esomeprazole resulting in a loss in efficacy.
Netupitant
The serum concentration of Esomeprazole can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Esomeprazole can be increased when combined with Nevirapine.
Nicardipine
The metabolism of Esomeprazole can be decreased when combined with Nicardipine.
Nicotine
The metabolism of Nicotine can be decreased when combined with Esomeprazole.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Esomeprazole.
Nilotinib
The serum concentration of Nilotinib can be decreased when it is combined with Esomeprazole.
Nilutamide
The metabolism of Nilutamide can be decreased when combined with Esomeprazole.
Nortriptyline
The metabolism of Nortriptyline can be decreased when combined with Esomeprazole.
Olaparib
The metabolism of Esomeprazole can be decreased when combined with Olaparib.
Omeprazole
The metabolism of Esomeprazole can be decreased when combined with Omeprazole.
Osimertinib
The serum concentration of Esomeprazole can be increased when it is combined with Osimertinib.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Esomeprazole.
Oxiconazole
The metabolism of Oxiconazole can be decreased when combined with Esomeprazole.
Palbociclib
The serum concentration of Esomeprazole can be increased when it is combined with Palbociclib.
Pamidronate
The therapeutic efficacy of Pamidronate can be decreased when used in combination with Esomeprazole.
Pamidronic Acid
The therapeutic efficacy of Pamidronate can be decreased when used in combination with Esomeprazole.
Pantoprazole
The metabolism of Esomeprazole can be decreased when combined with Pantoprazole.
Pazopanib
The serum concentration of Pazopanib can be decreased when it is combined with Esomeprazole.
Pentamidine
The metabolism of Pentamidine can be decreased when combined with Esomeprazole.
Pentobarbital
The metabolism of Esomeprazole can be increased when combined with Pentobarbital.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Esomeprazole.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Esomeprazole.
Phenindione
The serum concentration of Phenindione can be increased when it is combined with Esomeprazole.
Phenobarbital
The metabolism of Esomeprazole can be increased when combined with Phenobarbital.
Phenprocoumon
The serum concentration of Phenprocoumon can be increased when it is combined with Esomeprazole.
Phenytoin
The metabolism of Esomeprazole can be increased when combined with Phenytoin.
Pipothiazine
The metabolism of Pipotiazine can be decreased when combined with Esomeprazole.
Podofilox
The metabolism of Podofilox can be decreased when combined with Esomeprazole.
Posaconazole
The serum concentration of Posaconazole can be decreased when it is combined with Esomeprazole.
Prasugrel
The metabolism of Prasugrel can be decreased when combined with Esomeprazole.
Praziquantel
The metabolism of Praziquantel can be decreased when combined with Esomeprazole.
Primidone
The metabolism of Esomeprazole can be increased when combined with Primidone.
Progesterone
The metabolism of Progesterone can be decreased when combined with Esomeprazole.
Proguanil
The metabolism of Proguanil can be decreased when combined with Esomeprazole.
Promazine
The metabolism of Promazine can be decreased when combined with Esomeprazole.
Propofol
The metabolism of Propofol can be decreased when combined with Esomeprazole.
Propranolol
The metabolism of Propranolol can be decreased when combined with Esomeprazole.
Quazepam
The metabolism of Quazepam can be decreased when combined with Esomeprazole.
Quetiapine
The metabolism of Quetiapine can be decreased when combined with Esomeprazole.
Quetiapine fumarate
The metabolism of Quetiapine can be decreased when combined with Esomeprazole.
Quinine
The metabolism of Quinine can be decreased when combined with Esomeprazole.
Rabeprazole
The metabolism of Rabeprazole can be decreased when combined with Esomeprazole.
Raltegravir
The serum concentration of Raltegravir can be increased when it is combined with Esomeprazole.
Ramelteon
The metabolism of Ramelteon can be decreased when combined with Esomeprazole.
Ranitidine
The metabolism of Ranitidine can be decreased when combined with Esomeprazole.
Ranolazine
The metabolism of Esomeprazole can be decreased when combined with Ranolazine.
Rifabutin
The metabolism of Esomeprazole can be increased when combined with Rifabutin.
Rifampin
The serum concentration of Esomeprazole can be decreased when it is combined with Rifampicin.
Rifapentine
The metabolism of Esomeprazole can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Esomeprazole.
Riociguat
The serum concentration of Riociguat can be decreased when it is combined with Esomeprazole.
Risedronate
The therapeutic efficacy of Risedronate can be decreased when used in combination with Esomeprazole.
Risedronic Acid
The therapeutic efficacy of Risedronate can be decreased when used in combination with Esomeprazole.
Romidepsin
The metabolism of Romidepsin can be decreased when combined with Esomeprazole.
Rosuvastatin
The metabolism of Rosuvastatin can be decreased when combined with Esomeprazole.
Rucaparib
The metabolism of Esomeprazole can be decreased when combined with Rucaparib.
Saquinavir
The serum concentration of Saquinavir can be increased when it is combined with Esomeprazole.
Saquinavir Mesylate
The serum concentration of Saquinavir can be increased when it is combined with Esomeprazole.
Sarilumab
The therapeutic efficacy of Esomeprazole can be decreased when used in combination with Sarilumab.
Selegiline
The metabolism of Selegiline can be decreased when combined with Esomeprazole.
Sertraline
The metabolism of Sertraline can be decreased when combined with Esomeprazole.
Sildenafil
The metabolism of Esomeprazole can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Esomeprazole can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Esomeprazole can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Esomeprazole can be decreased when it is combined with St. John's Wort.
Sucroferric Oxyhydroxide
Esomeprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sulfisoxazole
The metabolism of Esomeprazole can be decreased when combined with Sulfisoxazole.
Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Esomeprazole.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Esomeprazole.
Tapentadol
The metabolism of Tapentadol can be decreased when combined with Esomeprazole.
Technetium Tc 99m Medronate
The therapeutic efficacy of Technetium Tc-99m medronate can be decreased when used in combination with Esomeprazole.
Telaprevir
The metabolism of Esomeprazole can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Esomeprazole can be decreased when combined with Telithromycin.
Temazepam
The metabolism of Temazepam can be decreased when combined with Esomeprazole.
Teniposide
The metabolism of Teniposide can be decreased when combined with Esomeprazole.
Terbinafine
The metabolism of Terbinafine can be decreased when combined with Esomeprazole.
Testosterone
The metabolism of Testosterone can be decreased when combined with Esomeprazole.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Esomeprazole.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Esomeprazole.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Esomeprazole.
Tetrahydrocannabinol
The metabolism of Dronabinol can be decreased when combined with Esomeprazole.
Thalidomide
The metabolism of Thalidomide can be decreased when combined with Esomeprazole.
Thioridazine
The metabolism of Thioridazine can be decreased when combined with Esomeprazole.
Ticlopidine
The metabolism of Esomeprazole can be decreased when combined with Ticlopidine.
Tiludronate
The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Esomeprazole.
Tiludronic Acid
The therapeutic efficacy of Tiludronic acid can be decreased when used in combination with Esomeprazole.
Timolol
The metabolism of Timolol can be decreased when combined with Esomeprazole.
Timolol Anhydrous
The metabolism of Timolol can be decreased when combined with Esomeprazole.
Tipranavir
The serum concentration of Esomeprazole can be decreased when it is combined with Tipranavir.
Tocilizumab
The serum concentration of Esomeprazole can be decreased when it is combined with Tocilizumab.
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Esomeprazole.
Tolbutamide
The metabolism of Tolbutamide can be decreased when combined with Esomeprazole.
Tolterodine
The metabolism of Tolterodine can be decreased when combined with Esomeprazole.
Topiramate
The metabolism of Esomeprazole can be decreased when combined with Topiramate.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Esomeprazole.
Tranylcypromine
The metabolism of Esomeprazole can be decreased when combined with Tranylcypromine.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Esomeprazole.
Trimipramine
The metabolism of Trimipramine can be decreased when combined with Esomeprazole.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Esomeprazole.
Valproate
The metabolism of Valproic Acid can be decreased when combined with Esomeprazole.
Valproic Acid
The metabolism of Valproic Acid can be decreased when combined with Esomeprazole.
Vemurafenib
The serum concentration of Esomeprazole can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Esomeprazole can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Esomeprazole can be decreased when combined with Verapamil.
Voriconazole
The serum concentration of Esomeprazole can be increased when it is combined with Voriconazole.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Esomeprazole.
Warfarin
The serum concentration of Warfarin can be increased when it is combined with Esomeprazole.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Esomeprazole.
Ziprasidone
The metabolism of Esomeprazole can be decreased when combined with Ziprasidone.
Zoledronic Acid
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Esomeprazole.
Zoledronic Acid Anhydrous
The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Esomeprazole.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Esomeprazole.
